The Enterprise Value as of December 2025 (TTM) for Barinthus Biotherapeutics plc (BRNS) is -33263316.00

According to Barinthus Biotherapeutics plc’s latest financial reports and current stock price. The company's current Enterprise Value is -33263316.00. This represents a change of -9.92% compared to the average of -36925009.50 of the last 4 quarters.

Barinthus Biotherapeutics plc (BRNS) Historical Enterprise Value (quarterly & annually)

How has BRNS Enterprise Value performed in the past?

The mean historical Enterprise Value of Barinthus Biotherapeutics plc over the last ten years is 10.76M. The current -33263316.00 Enterprise Value has changed -31027.15% with respect to the historical average. Over the past ten years (40 quarters), BRNS's Enterprise Value was at its highest in in the March 2021 quarter at 326.00M. The Enterprise Value was at its lowest in in the December 2021 quarter at -206832000.00.

Barinthus Biotherapeutics plc (BRNS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Barinthus Biotherapeutics plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Barinthus Biotherapeutics plc (BRNS) Average Enterprise Value

How has BRNS Enterprise Value performed in the past?

The current Enterprise Value of Barinthus Biotherapeutics plc (BRNS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Barinthus Biotherapeutics plc (BRNS) Enterprise Value vs. Peers

How is BRNS’s Enterprise Value compared to its peers?

Barinthus Biotherapeutics plc’s Enterprise Value is less than CEL-SCI Corporation (51.39M), less than Karyopharm Therapeutics Inc. (112.81M), less than INmune Bio, Inc. (23.33M), less than Senti Biosciences, Inc. (76.24M), less than Mersana Therapeutics, Inc. (83.22M), less than Aligos Therapeutics, Inc. (26.21M), greater than OnKure Therapeutics, Inc. (-34012234.00), less than Medicus Pharma Ltd. Common Stock (33.87M), less than Tempest Therapeutics, Inc. (9.57M), less than Kezar Life Sciences, Inc. (20.85M),

Build a custom stock screener for Barinthus Biotherapeutics plc (BRNS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Barinthus Biotherapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Barinthus Biotherapeutics plc (BRNS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Barinthus Biotherapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.